These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10461836)

  • 1. The role of glycopeptide antibiotics in the treatment of infective endocarditis.
    Grüneberg RN; Antunes F; Chambers HF; Garau J; Graninger W; Menichetti F; Peetermans WE; Pittet D; Shah PM; Vogelaers D
    Int J Antimicrob Agents; 1999 Aug; 12(3):191-8. PubMed ID: 10461836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of teicoplanin on Staphylococcus aureus with heterointermediate susceptibility to glycopeptides in experimental infective endocarditis model.
    Vas KE; Török Á; Cordoş B; Vancea S; Brassai A; Székely E
    J Chemother; 2016 Oct; 28(5):446-9. PubMed ID: 25976829
    [No Abstract]   [Full Text] [Related]  

  • 3. Infective endocarditis and glycopeptides.
    Pittet D; Harding I
    J Infect; 1998 Sep; 37(2):127-35. PubMed ID: 9821086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
    Kaatz GW; Seo SM; Dorman NJ; Lerner SA
    J Infect Dis; 1990 Jul; 162(1):103-8. PubMed ID: 2141343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin.
    Fortún J; Navas E; Martínez-Beltrán J; Pérez-Molina J; Martín-Dávila P; Guerrero A; Moreno S
    Clin Infect Dis; 2001 Jul; 33(1):120-5. PubMed ID: 11389505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycopeptides in the treatment of staphylococcal infections.
    Daschner FD; Kropec A
    Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
    Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infectious endocarditis caused by a glycopeptide-resistant enterococus].
    Jouaihia W; Ghozzi R; Kamoun A; Baccar H; Bousnina A; Ben Redjeb S
    Tunis Med; 2000 Nov; 78(11):667-70. PubMed ID: 11155391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].
    Bouza E; Rodríguez-Créixems M; Muñoz P
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324
    [No Abstract]   [Full Text] [Related]  

  • 10. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.
    Falcone M; Russo A; Pompeo ME; Vena A; Marruncheddu L; Ciccaglioni A; Grossi P; Mancini C; Novelli A; Stefani S; Venditti M
    Int J Antimicrob Agents; 2012 Jan; 39(1):64-8. PubMed ID: 22047703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial endocarditis treated with intramuscular teicoplanin.
    Chauhan S; D'Cruz S; Sachdev A; Singh R
    Singapore Med J; 2007 Sep; 48(9):e248-9. PubMed ID: 17728952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of teicoplanin in localized experimental infections in rats.
    Arioli V; Berti M; Candiani G
    J Hosp Infect; 1986 Mar; 7 Suppl A():91-9. PubMed ID: 2871103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A closer look at vancomycin, teicoplanin, and antimicrobial resistance.
    Zeckel ML
    J Chemother; 1997 Oct; 9(5):311-31; discussion 332-5. PubMed ID: 9373787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis.
    Webster A; Wilson AP; Williams AH; Treasure T; Grüneberg RN
    Postgrad Med J; 1987 Aug; 63(742):621-4. PubMed ID: 2962071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial.
    Davey PG; Williams AH
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():43-50. PubMed ID: 1829076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides.
    Lichterfeld M; Ferraro MJ; Davis BT
    Int J Antimicrob Agents; 2010 Jan; 35(1):96. PubMed ID: 19896341
    [No Abstract]   [Full Text] [Related]  

  • 17. Allergic cross-reactivity of teicoplanin and vancomycin.
    McElrath MJ; Goldberg D; Neu HC
    Lancet; 1986 Jan; 1(8471):47. PubMed ID: 2867290
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.
    Cervera C; del Río A; García L; Sala M; Almela M; Moreno A; Falces C; Mestres CA; Marco F; Robau M; Gatell JM; Miró JM;
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):587-92. PubMed ID: 21723004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Challenges in the antimicrobial treatment of infective endocarditis. Role of daptomycin].
    Almirante B; Miró JM
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():26-32. PubMed ID: 22541972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infective endocarditis caused by Streptococcus agalactiae: time for beta-hemolytic streptococci to follow treatment recommendations for S. aureus?
    Sendi P
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):419-422. PubMed ID: 30680556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.